Thu, Nov 12, 2026 - Page 22
13819 indexed SquawkNews stories from this UTC day. Showing 2521-2640.
L
Snail, Inc. Reports Third Quarter 2026 Financial Results
Snail, Inc. Reports Third Quarter 2026 Financial Results CULVER CITY, Calif., Nov.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Park Dental Partners Announces Third Quarter 2026 Results
Park Dental Partners Announces Third Quarter 2026 Results MINNEAPOLIS, Nov. 12, 2026 (GLOBE NEWSWIRE
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
ProMIS Neurosciences Announces Third Quarter 2026 Financial Results and Reaffirms First Quarter 2027 Topline Data Timing
PRECISE-AD Phase 1b clinical trial in Alzheimer’s patients remains on track for unblinded 12-month t
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates
REMAIN-1 Pivotal Cohort met its six-month co-primary endpoint with high statistical significance (p=
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
CYRELA Q3 NET PROFIT 481 MLN REAIS VS IBES ESTIMATE 517 MLN REAIS
CYRELA Q3 NET PROFIT 481 MLN REAIS VS IBES ESTIMATE 517 MLN REAIS
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
IZEA Q3 2026 swings to net loss of $443,940 year over year; Q3 2026 revenue falls 23% to $6.2 million year over year
IZEA Q3 2026 swings to net loss of $443,940 year over year; Q3 2026 revenue falls 23% to $6.2 millio
EARNINGS | Nov 12, 2026, 09:07 PM UTC
M
Cisco shares rise 4% in extended trading after quarterly report
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Beeline Q3 2026 Revenue Increases 30% Year-Over-Year; Net Loss Decreases 6% and Adjusted EBITDA Loss Narrows 33% Sequentially
Proposed TYTL Acquisition Expected to Finalize Definitive Agreements Within Days Positioning Beeline
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
SoundThinking, Inc. Reports Third Quarter 2026 Financial Results
FREMONT, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- SoundThinking, Inc.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Jefferson Capital Reports Third Quarter 2026 Results
Record Collections Grow 35% to $319.2 Million and Deployments grow 111% to $318.0 Million Record Est
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Streamex Reports Third Quarter 2026 Results
Streamex Reports Third Quarter 2026 Results 240 net new ounces behind GLDY, up from 15 in Q2; Cask F
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
StoneCo Q3 Recurring Adjusted Net Profit 542 Million Reais Vs IBES Estimate 613 Million Reais
StoneCo Ltd. NASDAQ:STNE
EARNINGS | Nov 12, 2026, 09:07 PM UTC
M
Cisco sets FY revenue outlook at USD 74,800-75,800 million
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Erasca, Inc. (ERAS) Reports $51.3M Q3 Net Loss; Cash Position $947.8M
Erasca reported a Q3 2026 net loss of $51.3M, or $0.15 per share, versus $30.6M, or $0.11 per share, a year earlier. Cash, cash equivalents, and marketable securities were $947.8M at September 30, 2026, versus $341.8M at
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Citigroup Global Markets Holdings Files FWP
Citigroup Global Markets Holdings Inc. filed a Form FWP.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Wealthfront to Announce Fiscal Third Quarter 2027 Financial Results on December 3, 2026
PALO ALTO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Wealthfront Corporation (Nasdaq: WLTH), a tech
EQUITY | Nov 12, 2026, 09:07 PM UTC
M
Applied Materials Q1 EPS Seen at $4.26, Revenue at $10.89 Billion
LSEG IBES data shows estimates for Applied Materials' first-quarter earnings per share and revenue.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
IZEA Worldwide, Inc. (IZEA) Q3 Revenue Falls 23% to $6.2M; Net Loss Is $0.4M
IZEA reported Q3 2026 revenue of $6.2M, down 23% from $8.1M a year earlier. The company recorded a $0.4M net loss versus $0.1M net income in Q3 2025; its Q4 revenue outlook is not specified in the provided release text.M
EARNINGS | Nov 12, 2026, 09:07 PM UTC
H
Heartflow, Inc. (HTFL) Q3 Revenue Rose 57% to $72.9M
Heartflow reported Q3 revenue of $72.9M, up 57% year over year, and raised its 2026 guidance. Net loss was $11.5M versus $50.9M a year earlier; the prior-year result included significant noncash and debt-extinguishment i
EARNINGS | Nov 12, 2026, 09:07 PM UTC
H
Dillard’s, Inc. Q3 Net Income Rises to $130.9M
For the quarter ended October 31, 2026, Dillard’s reported net income of $130.9M, or $8.38 per share, versus $129.8M, or $8.31, a year earlier. Comparable-store sales rose 1%; 39-week net income was $479.1M versus $366.5
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Relmada Therapeutics 3Q Loss/Shr 12c >RLMD
Relmada Therapeutics 3Q Loss/Shr 12c >RLMD
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Dragonfly Energy Reports Third Quarter 2026 Results
Dragonfly Energy Reports Third Quarter 2026 Results Heavy-Duty Trucking Revenue More Than Doubled Se
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Curis Q3 loss per share narrows 80% to $1.94
Curis Q3 loss per share narrows 80% to $1.94 Curis’ third-quarter 2026 net loss widened 5% year
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Micron Executives to Join Fireside Chats at Two Conferences
Micron executives are scheduled to participate in fireside chats at the TomorrowX Summit and UBS Technology and AI Conference.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Micron Executives to Participate in Investor Events
Micron executives will participate in fireside chats at investor events; webcasts and replays will be available through the company’s investor relations website.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Electra Therapeutics Q3 Net Loss Widens to $23.9 Million
Electra Therapeutics Q3 Net Loss Widens to $23.9 Million Electra Therapeutics reported a third-q
EQUITY | Nov 12, 2026, 09:07 PM UTC
H
Mannatech, Incorporated (MTEX) Reports Third-Quarter 2026 Results
Mannatech reported third-quarter 2026 results. The release excerpt provides no net sales, earnings, or other headline financial figures.Material DetailsContext by AI AnalystThis is a quarterly-results update, but the sup
EARNINGS | Nov 12, 2026, 09:07 PM UTC
H
NuCana Reports Third Quarter 2026 Financial Results and Provides Business Update
Development Programme for NUC-7738 Advances with Three Presentations Planned at ESMO Immuno-Oncology & Advanced Therapies Congress in December 2026European Composition-of-Matter Patent Granted for NUC-7738NUC-3373 Develo
GEOPOLITICS | Nov 12, 2026, 09:07 PM UTC
L
BlossomHill Therapeutics, Inc. (BLSM) Reports $24.0M Q3 Net Loss; Cash Runway Into Q2 2028
BlossomHill reported a Q3 2026 net loss of $24.0M, or $1.29 per share, versus $16.0M, or $6.54 per share, in Q3 2025. It had $224.9M in cash at September 30, 2026, which it expects to fund operations into Q2 2028.Materia
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
VirTra Reports Third Quarter and Nine Months 2026 Financial Results
VirTra Reports Third Quarter and Nine Months 2026 Financial Results CHANDLER, Ariz., Nov. 12, 2026 (
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Erasca Reports Third Quarter 2026 Business Updates and Financial Results
ERAS-0015 granted FDA Fast Track Designation for metastatic pancreatic adenocarcinoma; advancing toward three potentially registration-enabling trials in pancreatic and lung cancersUpdated ERAS-0015 monotherapy and noncl
REGULATION | Nov 12, 2026, 09:07 PM UTC
L
Prime Medicine Reports Third Quarter 2026 Financial Results and Provides Business Updates
First patient dosed in global Phase 1/2 clinical trial of PM577a in Wilson disease, the first clinical study of an in vivo Prime Editing therapy from Prime Medicine; initial clinical data expected in 2027 ---- Received F
REGULATION | Nov 12, 2026, 09:07 PM UTC
L
MacroGenics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate Progress
ROCKVILLE, Md., Nov. 12, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. NASDAQ:MGNX, a clinical-stage biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
BioStem Technologies Reports Third Quarter 2026 Financial Results; Grows Hospital Revenue for Second Consecutive Quarter as Customers Expand
Hospital revenue grew sequentially to $6.8 million; customers purchasing two or more product lines u
EARNINGS | Nov 12, 2026, 09:07 PM UTC
H
Liftoff Mobile, Inc. (LFTO) Reports Q3 Results Above Guidance
Liftoff Mobile said Q3 2026 results came in well above the high end of previously published guidance. The release text provided does not include the financial results or guidance figures.Material DetailsContext by AI Ana
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
OPENWORLD, INC. Q3 REVENUE USD 7.4 MILLION
OPENWORLD, INC. Q3 REVENUE USD 7.4 MILLION
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Journey Medical Corporation (DERM) Reports Q3 Revenue Of $19.0M
Journey Medical reported Q3 2026 revenue of $19.0M. Emrosi revenue was $9.0M, up 84% from Q3 2025.Material DetailsContext by AI AnalystThis is a quarterly update for a commercial-stage pharmaceutical company, with Emrosi
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
FRACTYL HEALTH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATES
FRACTYL HEALTH REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATES
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Fluent Announces Third Quarter 2026 Financial Results; Commerce Media Solutions Revenue Doubles and Annual Run Rate Now Exceeds $145 Million
Q3 2026 revenue of $53.6 million up 14%; nine months 2026 revenue of $146.9 million Q3 2026 Commerce
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
TMC the metals company Inc. (TMC) Reports $28.4M Q3 Net Loss, Down From $184.5M
TMC reported a Q3 2026 net loss of approximately $28.4M, or $0.06 per share, versus $184.5M, or $0.46 per share, in Q3 2025. Cash was approximately $79.3M with no financial debt at September 30, 2026.Material DetailsCont
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
LIFEMD INC Q3 GROSS MARGIN 82%
LIFEMD INC Q3 GROSS MARGIN 82%
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
PARK DENTAL PARTNERS INC OUTLOOK FY REVENUE USD 262-265 MILLION
PARK DENTAL PARTNERS INC OUTLOOK FY REVENUE USD 262-265 MILLION
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
LIFEMD INC Q3 ADJUSTED EBITDA USD -400 THOUSAND VS. IBES ESTIMATE USD -1.1 MILLION
LIFEMD INC Q3 ADJUSTED EBITDA USD -400 THOUSAND VS. IBES ESTIMATE USD -1.1 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
OPENWORLD, INC. REPORTS 2026 THIRD QUARTER RESULTS; FIRST QUARTERLY RESULTS AS A NASDAQ-LISTED COMPANY
OPENWORLD, INC. REPORTS 2026 THIRD QUARTER RESULTS; FIRST QUARTERLY RESULTS AS A NASDAQ-LISTED COMPA
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
PLIANT THERAPEUTICS Q3 OPERATING INCOME USD -25.742 MILLION
PLIANT THERAPEUTICS Q3 OPERATING INCOME USD -25.742 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
Micron to Participate in TomorrowX Summit and UBS Global Technology and AI Conference
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
OPENWORLD, INC. Q3 ADJUSTED EBITDA USD 2.3 MILLION
OPENWORLD, INC. Q3 ADJUSTED EBITDA USD 2.3 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
IZEA Reports Q3 2026 Revenue of $6.2 million, 94% increase in Managed Services Bookings
Enterprise Relationships Remain Strong Amid Market UncertaintiesORLANDO, Fla., Nov. 12, 2026 (GLOBE NEWSWIRE) -- IZEA Worldwide, Inc. NASDAQ:IZEA, a leading influencer marketing company that makes Creator Economy solutio
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
OPENWORLD, INC. Q3 GROSS PROFIT USD 6.3 MILLION
OPENWORLD, INC. Q3 GROSS PROFIT USD 6.3 MILLION
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
VIRTRA Q3 REVENUE USD 7.6 MILLION
VIRTRA Q3 REVENUE USD 7.6 MILLION
EARNINGS | Nov 12, 2026, 09:07 PM UTC
H
Dragonfly Energy (DFLI) Reports $12.2M Sales and Approximately Breakeven Q4 EBITDA Outlook
Dragonfly Energy reported Q3 2026 net sales of $12.2M, below its approximately $13.5M guidance, and an Adjusted EBITDA loss of $2.3M versus $2.1M a year earlier. Q4 2026 guidance is approximately breakeven Adjusted EBITD
EARNINGS | Nov 12, 2026, 09:07 PM UTC
H
PEDEVCO Corp. (PED) Reports $9.2M Q3 Net Loss as Revenue Rises 411%
PEDEVCO reported Q3 2026 revenue of $35.5M, up 411% from $7.0M a year earlier, and a net loss of $9.2M versus a $0.3M loss. Adjusted EBITDA was $14.7M, compared with $4.3M.Material DetailsContext by AI AnalystThis is an
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Solésence Reports Record Third Quarter 2026 Financial Results
Third quarter revenue increases 38% year-over-year to $20.2 million Third quarter net income of $3.7
CRYPTO | Nov 12, 2026, 09:07 PM UTC
L
InspireMD, Inc. (NSPR) Q3 Revenue Falls 11.1% as Net Loss Narrows
Q3 2026 revenue fell 11.1% to $2.2M versus $2.5M a year earlier; net loss narrowed to $9.8M from $12.7M. InspireMD also received FDA approval for CGuard Prime in TCAR procedures, which it expects to approximately double
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
STREAMEX CORP Q3 OPERATING INCOME USD -17.975 MILLION
STREAMEX CORP Q3 OPERATING INCOME USD -17.975 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
STREAMEX CORP Q3 NET INCOME USD -17.46 MILLION
STREAMEX CORP Q3 NET INCOME USD -17.46 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
BlossomHill Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Highlights
Alignment with the US Food and Drug Administration (FDA) on 50 mg twice daily as the recommended Phase 2 dose for BH-30643 based on favorable PK, safety, and efficacy data to dateAnnounced SOLARA-2, the single-arm pivota
REGULATION | Nov 12, 2026, 09:07 PM UTC
L
PARK DENTAL PARTNERS INC OUTLOOK FY ADJUSTED EBITDA MARGIN 8.1-8.4%
PARK DENTAL PARTNERS INC OUTLOOK FY ADJUSTED EBITDA MARGIN 8.1-8.4%
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
PARK DENTAL PARTNERS INC OUTLOOK FY ADJUSTED EBITDA USD 21.2-22.2 MILLION
PARK DENTAL PARTNERS INC OUTLOOK FY ADJUSTED EBITDA USD 21.2-22.2 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
SoundThinking, Inc. (SSTI) Q3 Revenue $25.0M; Net Loss Widens to $8.5M
Q3 revenue was $25.0M versus $25.1M a year earlier; net loss widened to $8.5M from $2.0M. SoundThinking expects the pending Transom transaction to close in Q4 2026, subject to customary conditions.Material DetailsContext
EARNINGS | Nov 12, 2026, 09:07 PM UTC
H
LifeMD, Inc. (LFMD) Reports $44.6M Revenue Below Guidance
LifeMD reported Q3 2026 revenue of $44.6M, below guidance; it is resetting its Q4 and full-year outlook. Active subscribers were approximately 350,000, up 13% year over year and nearly flat sequentially.Material DetailsC
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
JEFFERSON CAPITAL INC Q3 EPS USD 0.76
JEFFERSON CAPITAL INC Q3 EPS USD 0.76
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
DYADIC INTERNATIONAL, INC. Q3 EPS USD -0.04
DYADIC INTERNATIONAL, INC. Q3 EPS USD -0.04
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights
Ipsoprubart Advancing in Global Registrational Program as Potential First Treatment for sHLH Broadly; Enrollment Completion Expected in Second Half of 2027Ipsoprubart Therapeutic Expansion Underway in Phase 1 Trial for T
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
ImmuCell Corporation (ICCC) Q3 Revenue Rises 46% to $8.0M
ImmuCell reported unaudited Q3 2026 revenue of $8.0M, up 46.0% year over year, and net income of $953K, up $1.1M. Gross margin was 44.2%, up 130 basis points year over year.Material DetailsContext by AI AnalystThis is a
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
Total revenues were $19.0 million for the third quarter of 2026Emrosi® revenues of $9.0 million increased 84% compared to the third quarter of 2025Company to hold conference call today at 4:30 p.m. ETSCOTTSDALE, Ariz., N
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Candel Therapeutics (CADL) Q3 Net Loss Widens To $21.9M; Cash Runway Into Q2 2028
Candel Therapeutics reported a Q3 2026 net loss of $21.9M versus $11.3M in Q3 2025. Cash and cash equivalents were $203.1M at September 30, 2026, and the company expects them to fund operations into Q2 2028.Material Deta
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Pliant Therapeutics, Inc. (PLRX) Reports Q3 Results; Financial Figures Not Included
Pliant reported third-quarter 2026 financial results but the release provides no financial figures. FORTIFY enrollment continues, and Pliant plans to share more details on its RNAi delivery platform in coming months.Mate
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
4D MOLECULAR THERAPEUTICS Q3 NET INCOME USD -78.056 MILLION VS. IBES ESTIMATE USD -74.2 MILLION
4D MOLECULAR THERAPEUTICS Q3 NET INCOME USD -78.056 MILLION VS. IBES ESTIMATE USD -74.2 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
FRACTYL HEALTH Q3 ADJUSTED EBITDA USD -16 MILLION
FRACTYL HEALTH Q3 ADJUSTED EBITDA USD -16 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
AmpliTech Group Reports Q3 2026 Revenue of $6.58 Million, Up 8.0% Year-over-Year, and 41.1% Nine-Month Gross Profit Growth
AmpliTech Group Reports Q3 2026 Revenue of $6.58 Million, Up 8.0% Year-over-Year, and 41.1% Nine-Mon
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
JEFFERSON CAPITAL INC Q3 REVENUE USD 185.5 MILLION VS. IBES ESTIMATE USD 174.8 MILLION
JEFFERSON CAPITAL INC Q3 REVENUE USD 185.5 MILLION VS. IBES ESTIMATE USD 174.8 MILLION
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
WIDEPOINT CORP Q3 NET INCOME USD -190 THOUSAND
WIDEPOINT CORP Q3 NET INCOME USD -190 THOUSAND
FX | Nov 12, 2026, 09:07 PM UTC
L
Mannatech Reports Financial Results for Third Quarter 2026
FLOWER MOUND, Texas, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
INTELLICHECK Q3 REVENUE USD 5.739 MILLION
INTELLICHECK Q3 REVENUE USD 5.739 MILLION
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Liftoff Mobile Announces Third Quarter 2026 Financial Results
REDWOOD CITY, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Liftoff Mobile, Inc. (“Liftoff”) NASDAQ:LFTO, a global leader in performance marketing and monetization solutions for the app economy, today announced financial res
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Equillium Reports Third Quarter 2026 Financial Results and Recent Corporate and Clinical Highlights
First participant dosed in Phase 1 clinical trial of EQ504, proof-of-mechanism data expected in Q2 2
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
InspireMD Reports Third Quarter 2026 Financial Results
Received FDA approval of CGuard® Prime for Transcarotid Arterial Revascularization (TCAR) procedures, expected to approximately double the U.S. addressable market -- Company to host investor conference call today, Novemb
REGULATION | Nov 12, 2026, 09:07 PM UTC
L
ROC Delivers Record Quarterly Revenue of $8.0 Million in the Third-Quarter 2026, Up 50% YoY; Achieves Quarterly Profitability
Product revenue grew 24% to $5.7 million, driven by strong software licensing performance; gross mar
EARNINGS | Nov 12, 2026, 09:07 PM UTC
M
PRF Technologies Receives Nasdaq Delisting Determination, Requests Hearing
PRF Technologies received a Nasdaq delisting determination over the minimum bid price requirement and requested a hearing.
REGULATION | Nov 12, 2026, 09:07 PM UTC
L
4D MOLECULAR THERAPEUTICS Q3 REVENUE USD 4.145 MILLION VS. IBES ESTIMATE USD 2.7 MILLION
4D MOLECULAR THERAPEUTICS Q3 REVENUE USD 4.145 MILLION VS. IBES ESTIMATE USD 2.7 MILLION
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Codexis 3Q Rev $19.3M >CDXS
Codexis 3Q Rev $19.3M >CDXS
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Azora Therapeutics, Inc. (AZR) Reports $64.6M Q3 Loss, Including $57.1M Non-Cash Charge
Azora reported a Q3 2026 net loss of $64.6M, or $4.52 per share, versus $1.8M, or $2.02 per share, in Q3 2025; the 2026 loss included a $57.1M non-cash warrant-liability charge. Cash was $22.0M versus $28.7M at June 30,
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
SELLAS LIFE SCIENCES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
SELLAS LIFE SCIENCES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Alumis (ALMS) Reports Q3 Results; Psoriasis NDA on Track for Q4 2026
Alumis reported third-quarter 2026 financial results and business updates. New Phase 3 psoriasis data showed a 54% PASI 100 response rate at 48 weeks; an NDA submission remains on track for Q4 2026.Material DetailsContex
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update NDV-0
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
LifeMD Reports Third Quarter 2026 Results
Conference call begins at 4:30 p.m. Eastern time todayNEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. NASDAQ:LFMD, a leading provider of virtual primary care and pharmacy services, today reported financial resul
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
RELMADA THERAPEUTICS Q3 EPS USD -0.12
RELMADA THERAPEUTICS Q3 EPS USD -0.12
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Solésence, Inc. Q3 Revenue Rises 38% to $20.2M
Solésence reported Q3 2026 revenue of $20.2M, up 38% year over year, and net income of $3.7M, its highest in company history. The release provided no prior-period net income figure.Material DetailsContext by AI AnalystTh
CRYPTO | Nov 12, 2026, 09:07 PM UTC
L
Dragonfly Energy Reports Third Quarter 2026 Results
Heavy-Duty Trucking Revenue More Than Doubled Sequentially as Fleet Adoption AcceleratesTrucking Momentum Expected to Continue, With Q4 2026 Trucking Revenue Projected to Nearly Double on a Sequential BasisCompleted Acqu
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
JEFFERSON CAPITAL REPORTS THIRD QUARTER 2026 RESULTS
JEFFERSON CAPITAL REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
WIDEPOINT CORP Q3 EBITDA USD 230 THOUSAND
WIDEPOINT CORP Q3 EBITDA USD 230 THOUSAND
FX | Nov 12, 2026, 09:07 PM UTC
L
Digital Realty Declares Quarterly Cash Dividends for Common and Preferred Stock
EQUITY | Nov 12, 2026, 09:07 PM UTC
M
Applied Materials Forecasts Quarterly Revenue Above Estimates on AI Chip Demand
Applied Materials forecast quarterly revenue above estimates, citing strong AI chip demand.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
CANDEL THERAPEUTICS Q3 BASIC EPS USD -0.28
CANDEL THERAPEUTICS Q3 BASIC EPS USD -0.28
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
LIFEMD REPORTS THIRD QUARTER 2026 RESULTS
LIFEMD REPORTS THIRD QUARTER 2026 RESULTS
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
VIRTRA Q3 EPS USD 0.19
VIRTRA Q3 EPS USD 0.19
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Codexis 3Q Loss $8.13M >CDXS
Codexis 3Q Loss $8.13M >CDXS
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Codexis 3Q Loss/Shr 8c >CDXS
Codexis 3Q Loss/Shr 8c >CDXS
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Shimmick Corporation Announces Third Quarter 2026 Results
IRVINE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Shimmick Corp.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
STREAMEX CORP Q3 PRETAX PROFIT USD -18.043 MILLION
STREAMEX CORP Q3 PRETAX PROFIT USD -18.043 MILLION
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
JEFFERSON CAPITAL INC Q3 ADJUSTED PRETAX PROFIT USD 63.3 MILLION
JEFFERSON CAPITAL INC Q3 ADJUSTED PRETAX PROFIT USD 63.3 MILLION
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
PARK DENTAL PARTNERS INC Q3 ADJUSTED EPS USD 0.57
PARK DENTAL PARTNERS INC Q3 ADJUSTED EPS USD 0.57
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
WIDEPOINT CORP Q3 BASIC EPS USD -0.02
WIDEPOINT CORP Q3 BASIC EPS USD -0.02
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
Dillard’s, Inc. Reports Third Quarter and Year-to-Date Results
LITTLE ROCK, Ark., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Dillard’s, Inc. TXSE:DDS (the “Company” or “Dillard’s”) announced operating results for the 13 and 39 weeks ended October 31, 2026. This release contains certain forwa
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
XTI Aerospace Secures Waiver on $20 Million JPMorgan Credit Facility
XTI Aerospace secured a cross-default waiver on a $20 million JPMorgan Chase credit facility.
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
OPENWORLD, INC. Q3 GROSS MARGIN 80%
OPENWORLD, INC. Q3 GROSS MARGIN 80%
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
PARK DENTAL PARTNERS INC Q3 ADJUSTED GROSS MARGIN 18.6%
PARK DENTAL PARTNERS INC Q3 ADJUSTED GROSS MARGIN 18.6%
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Jefferson Capital Reports Third Quarter 2026 Results
Jefferson Capital Reports Third Quarter 2026 Results Record Collections Grow 35% to $319.2 Million a
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
SoundThinking, Inc. Reports Third Quarter 2026 Financial Results
FREMONT, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- SoundThinking, Inc. NASDAQ:SSTI, a leading public safety technology company, today reported financial results for the third quarter ended September 30, 2026.Third Quarte
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Spero Therapeutics Announces Third Quarter 2026 Operating Results and Provides Business Update
Spero Therapeutics Announces Third Quarter 2026 Operating Results and Provides Business Update SP001
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
JEFFERSON CAPITAL INC Q3 ADJUSTED EPS USD 0.83
JEFFERSON CAPITAL INC Q3 ADJUSTED EPS USD 0.83
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
JEFFERSON CAPITAL INC Q3 ADJUSTED NET INCOME USD 51.3 MILLION
JEFFERSON CAPITAL INC Q3 ADJUSTED NET INCOME USD 51.3 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
AVAX One Reports Third Quarter 2026 Financial and Operating Results
Reaffirms Focus on Avalanche Digital Asset Treasury Strategy Strengthens Financial Position Through
RATES | Nov 12, 2026, 09:07 PM UTC
L
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026
PORTLAND, Maine, Nov. 12, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation NASDAQ:ICCC (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf healt
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
ALUMIS Q3 INCOME FROM OPERATIONS USD -99.076 MILLION
ALUMIS Q3 INCOME FROM OPERATIONS USD -99.076 MILLION
FX | Nov 12, 2026, 09:07 PM UTC
L
Crown Crafts 2Q Sales $19M >CRWS
Crown Crafts 2Q Sales $19M >CRWS
EQUITY | Nov 12, 2026, 09:07 PM UTC
L
Crown Crafts 2Q EPS 12c >CRWS
Crown Crafts 2Q EPS 12c >CRWS
EARNINGS | Nov 12, 2026, 09:07 PM UTC
L
PEDEVCO Reports Third Quarter 2026 Results
Expanded Rockies Portfolio Positioned to Drive Production Growth in 2027HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- PEDEVCO Corp. (NYSE American: PED) (“PEDEVCO” or the “Company”), a publicly traded energy company engaged
MNA | Nov 12, 2026, 09:07 PM UTC
L
SPERO THERAPEUTICS Q3 INCOME FROM OPERATION USD -41.913 MILLION
SPERO THERAPEUTICS Q3 INCOME FROM OPERATION USD -41.913 MILLION
FX | Nov 12, 2026, 09:07 PM UTC